| 74.36 Data as of May 24 |  +0.54 / +0.73%Today’s Change | 51.35 Today|||52-Week Range 75.73 | +17.47% Year-to-Date |
| Novartis AG Stock Buy Recommendation Reiterated (NVS) May 24 / TheStreet.com | Good News for Novartis' Ilaris - Analyst Blog May 15 / Zacks.com |
| 3 Stocks Dragging In The Drugs Industry May 23 / TheStreet.com | PDL BioPharma Misses Earnings Ests - Analyst Blog May 13 / Zacks.com |
| FDA Designation for Synageva Candidate - Analyst Blog May 22 / Zacks.com | Earnings Beat for PETS, Margins Up - Analyst Blog May 13 / Zacks.com |
| Positive Data on Novartis' Afinitor - Analyst Blog May 21 / Zacks.com | Doctors blast ethics of $100,000 cancer drugs Apr 25 / CNNMoney.com |
| Ireland Welcomes Watson Pharmaceuticals, an American Success May 20 / TheStreet.com |
| Previous close | 73.82 |
| Today’s open | 74.36 |
| Day’s range | 73.85 - 74.43 |
| Volume | 1,008,886 |
| Average volume (3 months) | 1,571,089 |
| Market cap | $178.7B |
| Dividend yield | 3.26% |
| Earnings growth (last year) | +10.15% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | +3.88% |
| P/E ratio | -- |
| Price/Sales | 2.52 |
| Price/Book | 2.37 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer Inc | -0.07 | -0.24% |
| SNYSanofi SA | +0.30 | +0.55% |
| MRKMerck & Co Inc | -0.17 | -0.36% |
| GSKGlaxoSmithKline PLC | +0.24 | +0.46% |
| Next reporting date | July 17, 2013 |
| EPS forecast (this quarter) | $1.28 |
| Annual revenue (last year) | $60.8B |
| Annual profit (last year) | $10.2B |
| Net profit margin | 16.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer Joseph Jimenez, MBA |
Chief Financial Officer Harry Kirsch |
Corporate headquarters Basel, Basel-stadt (basle Town) |
.
